About ELIAS Animal Health

Based in Olathe, Kan., ELIAS Animal Health is a medical biotechnology company advancing its novel targeted T cell-based immunotherapies for the treatment of canine cancers. The ELIAS cancer immunotherapy (ECI)®, an autologous prescription product, is being distributed to veterinarians under 9 CFR 103.3 as an experimental product. Efficacy and safety have not been established. The company’s novel therapeutic approach offers the promise of improved clinical outcomes and the potential for fundamentally changing the way cancer is treated.

ELIAS Cancer Immunotherapy